Antiepileptic and antiepileptogenic performance of carisbamate after head injury in the rat: Blind and randomized studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 779-790

  Eastman, Clifford L ^a   Verley, Derek R ^a   Fender, Jason S ^a   Stewart, Tessandra H ^a   Nov, Eytan ^a   Curia, Giulia ^a   D'Ambrosio, Raimondo ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARISBAMATE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CONTUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG METABOLISM; ELECTROCORTICOGRAPHY; EPILEPTOGENESIS; HEAD INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SEIZURE; STEADY STATE; TRAUMATIC EPILEPSY; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; CARBAMATES; CRANIOCEREBRAL TRAUMA; EPILEPSY, POST-TRAUMATIC; MALE; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; SINGLE-BLIND METHOD;

EID: 79951973042     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.175133     Document Type: Article

References (43)

1. André V, Dubé C, François J, Leroy C, Rigoulot MA, Roch C, Namer IJ, and Nehlig A (2007) Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia 48:41-47. (Pubitemid 47512201)
2. Beghi E, Berg A, Carpio A, Forsgren L, Hesdorffer DC, Hauser WA, Malmgren K, Shinnar S, Temkin N, Thurman D, and Tomson T (2005) Comment on epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 1698-1699.
3. Callaghan BC, Anand K, Hesdorffer D, Hauser WA, and French JA (2007) Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 62:382-389. (Pubitemid 350105952)
4. Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM, Macleod M, and Dirnagl U (2008) Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 39:929-934. (Pubitemid 351619572)
5. D'Ambrosio R and Miller JW (2010a) Point. Epilepsy Curr 10:90.
6. D'Ambrosio R and Miller JW (2010b) What is an epileptic seizure? Unifying definitions in clinical practice and animal research to develop novel treatments. Epilepsy Curr 10:61-66.
7. D'Ambrosio R, Fairbanks JP, Fender JS, Born DE, Doyle DL, and Miller JW (2004) Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 127: 304-314. (Pubitemid 38160315)
8. D'Ambrosio R, Fender JS, Fairbanks JP, Simon EA, Born DE, Doyle DL, and Miller JW (2005) Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat. Brain 128:174-188. (Pubitemid 40070531)
9. D'Ambrosio R, Hakimian S, Stewart T, Verley DR, Fender JS, Eastman CL, Sheerin AH, Gupta P, Diaz-Arrastia R, Ojemann J, et al. (2009) Functional definition of seizure provides new insight into post-traumatic epileptogenesis. Brain 132:2805-2821.
10. Duncan JS, Sander JW, Sisodiya SM, and Walker MC (2006) Adult epilepsy. Lancet 367:1087-1100.
11. Eastman CL, Verley DR, Fender JS, Temkin NR, and D'Ambrosio R (2010) ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the rat. Exp Neurol 224:369-388.
12. Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, and Haas M (2008) Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology 71:1586-1593.
13. Fisher RS and Leppik I. (2008) Debate: When does a seizure imply epilepsy? Epilepsia 49 (Suppl 9):7-12.
14. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, and Engel J Jr (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470-472. (Pubitemid 40470667)
15. French JA (2007) Refractory epilepsy: clinical overview. Epilepsia 48 (Suppl 1):3-7.
16. François J, Boehrer A, and Nehlig A (2008) Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia 49:393-399. (Pubitemid 351294523)
17. Glien M, Brandt C, Potschka H, and Löscher W (2002) Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 43:350-357. (Pubitemid 34297172)
18. Grabenstatter HL and Dudek FE (2008) A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 49:1787-1794.
19. Grabenstatter HL, Ferraro DJ, Williams PA, Chapman PL, and Dudek FE (2005) Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 46:8-14. (Pubitemid 40179927)
20. Hitiris N, Mohanraj R, Norrie J, Sills GJ, and Brodie MJ (2007) Predictors of pharmacoresistant epilepsy. Epilepsy Res 75:192-196. (Pubitemid 47048664)
21. Juul-Jensen P (1986) Epidemiology of intractable epilepsy, in Intractable Epilepsy (Schmidt D and Morselli P, eds) pp 5-11, Raven Press, New York.
22. Klein BD, Smith MD, and White HS (2007) The novel neuromodulator carisbamate delays the acquisition of rat amygdala kindling and maintains acute antiepileptic activity when evaluated in post-kindled rats. Epilepsia 48 (Suppl 6):367-368.
23. Kwan P and Brodie MJ (2003) Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 60 (Suppl 4):S2-S12. (Pubitemid 36736307)
24. LöscherW(2002) Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50:105-123.
25. Löscher W (2007) The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy. Epilepsia 48:1245-1258.
26. Löscher W and Hönack D (1995) Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats. Epilepsia 36:929-937.
27. Löscher W and Schmidt D (2004) New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 60:77-159. (Pubitemid 39486027)
28. Lu Y, Yu W, and Wang X (2009) Efficacy of topiramate in adult patients with symptomatic epilepsy: an open-label, long-term, retrospective observation. CNS Drugs 23:351-359.
29. Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, and Meuldermans W (2007) Metabolism and excretion of RWJ-333369 [1,2-ethanediol,1-(2-chlorophenyl)-,2-carbamate,(S)-] in mice, rats, rabbits, and dogs. Drug Metab Dispos 35:566-575. (Pubitemid 46513258)
30. Mattson RH, Cramer JA, and Collins JF (1996) Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology 47:68-76. (Pubitemid 26243861)
31. Meldrum B (2002) Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs? Epilepsy Res 50:33-40.
32. Novak GP, Kelley M, Zannikos P, and Klein B (2007) Carisbamate (RWJ-333369). Neurotherapeutics 4:106-109. (Pubitemid 46107332)
33. Philip M, Benatar M, Fisher M, and Savitz SI (2009) Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke 40:577-581.
34. Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69:273-294.
35. Schmidt D and Rogawski MA (2002) New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res 50:71-78. (Pubitemid 34876588)
36. Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, and Baulac M (1998) Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51:1256-1262. (Pubitemid 28520540)
37. Sperling MR, Greenspan A, Cramer JA, Kwan P, Kälviäinen R, Halford JJ, Schmitt J, Yuen E, Cook T, Haas M, et al. (2010) Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials. Epilepsia 51:333-343.
38. Stables JP, Bertram EH, White HS, Coulter DA, Dichter MA, Jacobs MP, Loscher W, Lowenstein DH, Moshe SL, Noebels JL, et al. (2002) Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 43:1410-1420. (Pubitemid 35365001)
39. Temkin N (2009) Preventing and treating posttraumatic epilepsy: the human experience. Epilepsia 50 (Suppl 2):10-13.
40. Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, Hovda DA, and McIntosh TK (2005) Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma 22:42-75.
41. White HS (2002) Animal models of epileptogenesis. Neurology 59 (Suppl 5):S7-S14.
42. White HS (2003) Preclinical development of antiepileptic drugs: past, present, and future directions. Epilepsia 44 (Suppl 7):2-8.
43. White H, Srivastava A, Klein B, Zhao B, Choi YM, Gordon R, and Lee JS (2006) The novel investigational neuromodulator RWJ-333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models. Epilepsia 47:200-201.